When it comes to the use of PD-1 inhibitors in stomach cancer, the FDA has put its money where its mouth is. | After ...

A new immunotherapy for treating stomach cancer is helping people live 40% longer. However, some are affected by this ...

After eating, your body gets to work breaking down the food into nutrients for fuel. “Walking accelerates gut motility and ...

Drugs that boost the body’s immune system to fight disease are showing promise in treating a variety of cancers in earlier ...

Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI ® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...

Stomach cancer is particularly common in Asia, including in China, Japan, and India. GEJA is a type of cancer that occurs in the gastroesophageal junction, which is where the esophagus meets the ...

Immunotherapy combined with chemo can give people a fighting chance against stomach and esophageal cancers, a new clinical ...

Discover why GERD without esophagitis causes severe symptoms despite normal endoscopy results. Learn 8 hidden mechanisms ...

They found that PAF caused strong contractions—especially in the muscles of the esophagus and the stomach's upper region (called the gastric fundus). These two regions share a common origin in ...

PAF causes strong contractions—especially in the muscles of the esophagus and the stomach’s upper region (called the gastric fundus). In other parts of the intestine, such as the small ...